Major pharmaceutical firms' earnings improving

Published: 2006-11-08 07:00:00

Updated: 2006-11-08 07:00:00

Leading drug makers have seen their earnings improve steadily in the January-September period due to profit-oriented management strategies instead of expanding sales, according to pharmaceutical business sources.

These companies listed on the main bourse - Korea Stock Exchange have focused on...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK